Compliance
The regulatory misconception: FDA approval vs. standard of care
One of the most common misconceptions we encounter when speaking with physicians is the belief that FDA approval is the primary determinant of whether a peptide may be appropriately used in clinical practice.
In reality, FDA approval and the medical standard of care are related concepts, but they are not the same thing.
Who regulates what
The FDA regulates drug approval, manufacturing, labeling, and interstate commerce. State medical boards regulate the practice of medicine.
Physicians are ultimately evaluated by their own licensing authorities based on whether they exercised appropriate clinical judgment and complied with the applicable standard of care.
That distinction matters.
The questions that matter
When physicians evaluate any therapy, the relevant questions are typically:
- Is there a legitimate clinical rationale?
- Has the patient been properly evaluated?
- Have appropriate diagnostics been performed?
- Has informed consent been obtained?
- Is the patient being monitored appropriately?
- Is the treatment decision adequately documented?
Those are the questions that frequently arise in professional liability and medical board proceedings.
How this shapes what Cascadia does
Product quality and physician diligence
At Cascadia, we believe that product quality and physician diligence should work together. That is why our platform is built around three core safety protocols:
- Comprehensive laboratory testing, including molecular purity, sterility, endotoxin, and heavy metal analysis.
- Batch tracking and traceability to ensure that testing results correspond to the specific material being supplied.
- Supplier qualification and inspection procedures designed to evaluate the reliability and consistency of our sourcing partners.
Our role, and the physician's
Our role is not to practice medicine. That responsibility belongs to the physician.
Our role is to provide physicians with transparent information regarding sourcing, testing, and quality controls so that they can make informed decisions consistent with their own professional judgment and the requirements of their state.
When a physician combines rigorous clinical evaluation with rigorous product diligence, they place themselves in a stronger position to defend the quality of their medical decision-making.
That is the philosophy behind the Cascadia Safety Protocol.
RSVP for the next webinar Talk to a practice consultantWe reply within one business day.
Get a free state- and peptide-specific compliance memo + informed consent template →
More articles
- GHK-Cu and the Cellular Craft of Tissue Repair
- How Semaglutide and Tirzepatide Change the Conversation Between Cells
- Glutathione and the Chemistry of Cellular Defense
- SS-31 and the Membrane That Powers Your Cells
- Potential legal exposure associated with purchasing ineligible compounded peptides from a 503A pharmacy
- Compounded tirzepatide vs. Mounjaro: why patients are asking, and how it fits a practice
- How to add peptide therapy to your practice: a step-by-step overview
- A practical telehealth workflow for peptide prescribing
- Building a peptide patient program that patients stick with